Health
Rutgers leading coronavirus therapeutic clinical trial – EurekAlert
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with…
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted with Synavir Corporation, a global health company that works with academia, industry and government to develop combination treatments for new viral infections.
The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine…
-
Noosa News16 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General17 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business23 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General22 hours agoStocks, dollar sink as trade war roils markets